NCT00004863View on ClinicalTrials.gov

Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

GEM 231

DRUG

paclitaxel

Trial Locations (1)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Montefiore Medical Center

OTHER

NCT00004863 - Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter